Intel Is Selling $20 Billion in New Stock — Here's Why That Matters for Your Money

Intel announced on August 10, 2026 that it will sell 210.5 million shares of stock at $95 each, raising $20 billion (WSJ). The sale was expected to close on August 12, 2026, assuming standard conditions are met (Intel Newsroom). The company may sell even more shares if demand is strong, pushing the total above $20 billion (The Business Times).

This is not Intel's first fundraising move this year. In April 2026, the company sold additional stock and issued $1 billion in bonds — a type of loan from investors that pays fixed interest — at 4.650% (SEC filing). As of April 17, 2026, Intel had 5,026 million shares outstanding (SEC filing). The 210.5 million new shares mean existing shareholders' ownership shrinks by about 4.2% — a process called dilution.

SoftBank and the Government

The $20 billion raise is the biggest part of a larger plan that also includes money from SoftBank and the federal government. SoftBank Group signed a $2 billion deal to buy Intel stock at $23 per share (Intel Newsroom). That $23 price is about 76% below the $95 public offering price. The gap likely reflects special conditions attached to the private deal — such as restrictions on when SoftBank can sell — though the specific terms are not detailed in verified materials.

Separately, Intel and the Trump Administration reached an agreement giving the federal government the right to buy five percent of Intel's stock at $20 per share within five years (Intel Newsroom, published August 22, 2025). That right, called a warrant, costs the government far less per share than what public investors are paying. It functions as both a capital injection and a potential ownership stake.

The government involvement builds on prior CHIPS Act funding. Intel and the Biden administration announced up to $8.5 billion in direct funding under the CHIPS Act on March 20, 2024 (Intel Newsroom). The Trump-era warrant agreement added more federal capital exposure on top of that earlier grant.

Revenue, Spending, and Why Intel Needs the Cash

Intel Products revenue was $15.1 billion in Q2 2026 and $27.9 billion year-to-date (SEC filing). The company's research and development spending has been falling: $13.8 billion in 2025, down from $16.5 billion in 2024 and $16.0 billion in 2023 (SEC filing). On July 24, 2026, Intel forecast third-quarter revenue above Wall Street expectations and raised its full-year capital expenditure estimate to $20 billion (Reuters).

The raised spending target and the $20 billion equity raise are almost exactly the same size. That is not a coincidence. Intel is funding a large chunk of its planned investment with new stock rather than borrowing money. The April bond sale of $1 billion was small by comparison, suggesting debt was not the main funding channel for the bigger program.

For existing shareholders, the math is simple but adds up across multiple deals. The 210.5 million new shares at $95 bring in roughly $20 billion. SoftBank's purchase at $23 adds more shares at a steep discount. The government's warrant for five percent of shares at $20 creates still more potential dilution if it is exercised. Together, the actual and possible increase in total shares is significant compared to the 5,026 million shares Intel had outstanding as of April.

The broader context here is a company cutting research spending, increasing factory investment, and selling stock at the same time. Intel's R&D fell from $16.5 billion in 2024 to $13.8 billion in 2025, a drop of about 16%. Over the same period, the company committed to $20 billion in annual capital expenditure — money spent building things like chip factories. The shift suggests Intel is moving money from research into physical manufacturing capacity, funded in part by selling stock rather than using its own cash. Whether that bet pays off depends on whether the new factories start making money fast enough to offset the cost of all those new shares.

The timing, after a strong Q2 and an optimistic Q3 forecast, suggests Intel is taking advantage of positive market sentiment to sell shares at a good price. The $95 public price is far above the $23 SoftBank paid and the $20 government warrant price, reflecting the difference between a public market sale and private or government deals with different terms.

If the over-allotment option is exercised, total proceeds will exceed $20 billion and dilution will increase accordingly. The closing depends on standard conditions, and the sale is a straightforward common stock offering — not a more complex instrument like convertible or preferred shares.